Comparison of The effect between two dose (800 µg/day & 400 µg/6) of vaginal misoprostol in the termination of first-trimester pregnancy: a double-blinded randomized trial
Phase 3
Completed
- Conditions
- need to medical abortion due to maternal indications or missed abortion and blighted ovum.Medical abortion : incomplete, complicated by delayed or excessive haemorrhage
- Registration Number
- IRCT2017040633255N1
- Lead Sponsor
- vice chancellor for research of Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Inclusion Criteria: singleton pregnancy; indication for pregnancy termination due to either fetal or maternal causes and gestational age lower than 96 days; no previous misoprostol consuming.
exclusion criteria: any sign or symptom of threatened; spontaneous abortion before therapy such as bleeding; any degree of dilatation in cervix or uterine regular contractions before drug administration.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete abortion without needing to a surgery. Timepoint: once. Method of measurement: observed by the obstetrician.
- Secondary Outcome Measures
Name Time Method Persistent Bleeding. Timepoint: once. Method of measurement: observed by obstetricans.